why choose us

First received: July 29, 2025

Clinical Trial: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBD09

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy Adult Participants

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Trial in Healthy Adult Participants to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBD09 With an 84-day Period of

Brief Summary: This is a randomized, double-blind, placebo-controlled, multiple dose trial of TBD09, administered to healthy adult participants to assess safety, tolerability, and pharmacokinetics up to 84 days of fixed daily dosing of TBD09.The trial will be conducted with two cohorts, with participants enrolled in parallel and randomized to receive either TBD09 or placebo.

Read more